🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To establish the bioequivalence between Acarbose / Metformin FDC (50mg / 50...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01728740
Treatments Being Tested
This study is a proof of concept study to demonstrate that EMP16-02, a fixe...
Status
Completed
Location
Clinical Trial Consultants AB
Start Date
2020-05-07
Trial ID
NCT04521751
Treatments Being Tested
This Phase II pragmatic hybrid effectiveness-implementation trial tests whe...
Status
Completed
Location
Shifa International hospital
Start Date
2025-09-01
Trial ID
NCT07436585
Treatments Being Tested
This is a prospective randomized controlled trial. . Patients will be divid...
Status
Unknown
Location
Changhai Hospital
Start Date
2022-03
Trial ID
NCT05261997
Postprandial hypotension carries a risk of significant morbidity and morbid...
Status
Completed
Location
VITALiTY Research Centre
Start Date
2007-06
Trial ID
NCT02043886
The purpose of this study is to establish the bioequivalence (i.e. similar ...
Status
Completed
Location
Zhongshan Hospital, Fudan University
Start Date
2019-10-14
Trial ID
NCT04065581
Treatments Being Tested
Obesity is increasing worldwide and consequently the need for efficient tre...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02527993
Is a randomized, double-blind, placebo-controlled trial to determine the be...
Status
Completed
Location
Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán
Start Date
2010-01
Trial ID
NCT02355509
Objectives: Thiazolidinediones (TZDs) are insulin sensitizers that decreas...
Status
Unknown
Location
Taipei Veterans General Hospital, Taiwan
Start Date
2010-07
Trial ID
NCT01175486
Treatments Being Tested
This is a 24-week, multicenter, randomized, open-label, parallel-group, act...
Status
Terminated
Location
Research Site
Start Date
2017-12-15
Trial ID
NCT03344341
Treatments Being Tested